Ceftriaxone & Tazobactam Injection 1.5 g: Supplier for London, United Kingdom
Trusted Sterile Antibiotic Injection Manufactured in India
Ernest Oncology presents Ceftriaxone & Tazobactam Injection 1.5 g, a sterile injectable antibiotic developed by combining Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. This advanced formulation enhances antibacterial effectiveness against susceptible bacteria when administered under professional medical supervision.
Manufactured in India within WHO-GMP certified pharmaceutical facilities, the product reflects strict quality standards, modern production technology, and consistent manufacturing excellence.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 1.5 g |
| Active Ingredients | Ceftriaxone + Tazobactam |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Dual-action antibacterial formulation
- Ceftriaxone and Tazobactam combination
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- Broad-spectrum antibacterial activity
- Stable pharmaceutical formulation
- Reliable batch consistency
- Export-quality packaging
- High manufacturing standards
- Stringent quality control procedures
Product Description
Ceftriaxone & Tazobactam Injection 1.5 g is a sterile injectable antibiotic formulated to provide enhanced antibacterial activity against susceptible bacterial infections. The combination of Ceftriaxone and Tazobactam helps improve treatment effectiveness by protecting the antibiotic from bacterial beta-lactamase enzymes.
The medicine is administered by qualified healthcare professionals through intramuscular (IM) or intravenous (IV) injection according to approved prescribing guidelines.
Mechanism of Action
The formulation delivers antibacterial activity through complementary mechanisms.
- Ceftriaxone inhibits bacterial cell wall synthesis, leading to bacterial cell destruction.
- Tazobactam blocks beta-lactamase enzymes that can reduce antibiotic effectiveness, helping preserve Ceftriaxone's antibacterial action.
Together they provide broader coverage against susceptible bacterial pathogens.
Side Effects
Like other prescription antibiotics, some individuals may experience temporary side effects.
Possible reactions include:
- Injection site discomfort
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzymes
Medical advice should be sought if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Use only under qualified medical supervision.
- Inform your doctor about any allergies before treatment.
- Complete the prescribed treatment course.
- Follow healthcare instructions carefully.
- Do not use after the expiry date.
- Keep out of reach of children.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in the original packaging
- Do not freeze
- Use before the expiry date
Recommended Dosage
The appropriate dosage should always be determined by a qualified healthcare professional.
Treatment depends upon:
- Nature of infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical assessment
The medicine should only be administered under medical supervision.
London Pharmaceutical Market Information
London is one of Europe's leading healthcare and pharmaceutical centers, supported by internationally recognized hospitals, research institutions, and specialist healthcare facilities. The healthcare sector continues to prioritize medicines manufactured according to globally accepted pharmaceutical quality standards.
Indian pharmaceutical manufacturers are well known for producing reliable sterile injectable medicines that combine modern manufacturing technology with internationally recognized quality systems.
Why Choose Indian Pharmaceutical Exports
India has become one of the world's most respected pharmaceutical manufacturing countries, supplying medicines to healthcare systems across more than 200 countries.
Benefits of Indian Pharmaceutical Manufacturing
- WHO-GMP certified production facilities
- Advanced sterile manufacturing technology
- International quality compliance
- High pharmaceutical purity
- Modern quality assurance systems
- Reliable batch consistency
- Export-quality packaging
- Strong global healthcare reputation
- Continuous manufacturing improvements
- Proven pharmaceutical expertise
Quality Assurance
Every batch manufactured for Ernest Oncology undergoes comprehensive quality verification before distribution.
Our Quality Commitment
- WHO-GMP certified manufacturing facilities
- Sterile production environment
- Batch quality testing
- Product traceability
- Export-standard packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality monitoring
Documentation
The following documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP) (where available)
- Batch Manufacturing Record* (where applicable)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
At Ernest Oncology, we are dedicated to improving global healthcare through high-quality pharmaceutical manufacturing. Every medicine reflects our commitment to scientific innovation, strict quality standards, and patient-focused healthcare solutions. By combining modern technology with internationally accepted manufacturing practices, we strive to deliver pharmaceutical products that healthcare professionals can rely on with confidence.
Frequently Asked Questions (FAQs)
1. What is Ceftriaxone & Tazobactam Injection 1.5 g?
It is a sterile injectable antibiotic combining Ceftriaxone and Tazobactam for the treatment of susceptible bacterial infections under medical supervision.
2. How is the injection administered?
It is administered through intramuscular (IM) or intravenous (IV) injection by qualified healthcare professionals.
3. Why is Tazobactam added to Ceftriaxone?
Tazobactam inhibits beta-lactamase enzymes, helping protect Ceftriaxone from bacterial resistance mechanisms and improving antibacterial effectiveness.
4. How should Ceftriaxone & Tazobactam Injection 1.5 g be stored?
Store below 25°C, protected from moisture and direct sunlight, in its original packaging.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine that should only be used under the supervision of a qualified healthcare professional.
📞 Contact Ernest Oncology — Supporting Better Healthcare Worldwide
A Specialized Healthcare Brand of Ernest Pharmaceutical Pvt. Ltd.
🌐 Explore Our Healthcare Network
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
Email: exports@ernestpharmaceuticals.com
🌍 Our Vision
- Advancing Global Healthcare
- Trusted Pharmaceutical Innovation
- Quality Medicines Manufactured in India
- Reliable Healthcare Solutions
+91 93599 02383
Medical Disclaimer
Ceftriaxone & Tazobactam Injection 1.5 g is a prescription-only medicine. The information provided on this page is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Description
Ernest Oncology supplies Ceftriaxone & Tazobactam Injection 1.5 g from India to London, UK. High-quality sterile antibiotic injection manufactured under WHO-GMP standards for international healthcare with reliable pharmaceutical quality.
- Ceftriaxone & Tazobactam Injection 281.25 mg
- Ceftriaxone & Tazobactam Injection 562.5 mg
- Ceftriaxone & Tazobactam Injection 1.125 g
- Ceftriaxone & Tazobactam Injection 1.5 g
- Ceftriaxone & Tazobactam Injection 2.25 g
Written By
Chaitali H.
B. Pharma
